🇺🇸 FDA
Patent

US 9952216

Brain-specific enhancers for cell-based therapy

granted A61KA61K35/545A61K48/00

Quick answer

US patent 9952216 (Brain-specific enhancers for cell-based therapy) held by The Regents of the University of California expires Mon Apr 19 2038 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue Apr 24 2018 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Apr 19 2038 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
10
CPC classes
A61K, A61K35/545, A61K48/00